Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fojo

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Journal of the National Cancer Institute|October 5, 2001
Cancer, DNA repair mechanisms, and resistance to chemotherapyT Fojo
The Oncologist|August 29, 2001
Novel_target.comT Fojo
Cancer Treatment and Research|January 1, 1989
Multidrug resistance in human tumorsA T Fojo
Advances in Internal Medicine|January 1, 1991
Multidrug resistanceA T Fojo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
TaxanesD Sackett, T Fojo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Discodermolide: just another microtubule-stabilizing agent? No! A lesson in synergyP Giannakakou, T Fojo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2007
Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agentsT Fojo, M Menefee
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Taxanes and other microtubule stabilizing agentsD L Sackett, T Fojo
Cancer Research|September 7, 2012
Why RECIST works and why it should stay--counterpointAntonio T Fojo, Anne Noonan
Cancer Research|September 7, 2012
RECIST: no longer the sharpest tool in the oncology clinical trials toolbox--reply to pointAntonio T Fojo, Anne Noonan
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Journal of the National Cancer Institute|October 5, 2001
Cancer, DNA repair mechanisms, and resistance to chemotherapyT Fojo
The Oncologist|August 29, 2001
Novel_target.comT Fojo
Cancer Treatment and Research|January 1, 1989
Multidrug resistance in human tumorsA T Fojo
Advances in Internal Medicine|January 1, 1991
Multidrug resistanceA T Fojo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
TaxanesD Sackett, T Fojo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Discodermolide: just another microtubule-stabilizing agent? No! A lesson in synergyP Giannakakou, T Fojo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2007
Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agentsT Fojo, M Menefee
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Taxanes and other microtubule stabilizing agentsD L Sackett, T Fojo
Cancer Research|September 7, 2012
Why RECIST works and why it should stay--counterpointAntonio T Fojo, Anne Noonan
Cancer Research|September 7, 2012
RECIST: no longer the sharpest tool in the oncology clinical trials toolbox--reply to pointAntonio T Fojo, Anne Noonan
Pageof 18